Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves bill to remove cost sharing for clinically‑appropriate genetic tests and related screening
Summary
Senators advanced House Bill 1079 to require insurers to eliminate cost sharing for clinically appropriate genetic tests and follow‑up screening; sponsor and survivors said earlier detection and tailored treatment could save lives and control downstream costs.
The Senate Insurance & Commerce Committee approved House Bill 1079, which would require insurers to cover clinically appropriate genetic tests and the follow‑up screenings those tests recommend without cost sharing when medically appropriate, supporters said.
Sponsor and testimony Sponsor Senator Dave Wallace described the bill as a “life‑saving” measure and said stakeholders worked collaboratively on the language. Representative Fred Allen (co‑sponsor) and physician testimony supported the bill.
Dr. Sam McCool, director of…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
